Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Phenomenex Announces Direct Sales And Support In Switzerland September 5, 2017 Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017 Bioverativ Execs Snagged a Nice Payday After Sanofi Deal February 8, 2018
Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017
